So we are now well on our way into the month of September. As I mentioned in last week’s post, we have entered the two wackiest months of the year. At least they are in my opinion. Now to add to that, this week we had a major bank come out and say we are […]
Read Article
VantagePoint Trading Software is a forecasting tool that uses both end of day data and artificial intelligence to provide traders a forecast of market movement. These forecasts are 1-3 days in advance and help traders improve their timing on making trades and maximizing profit potential. The artificial intelligence software forecasts market movement for stocks, futures, […]
Read Article
Thursday is going to be the day to watch this week. Tune in to this video and find out why!
Read Article
Shares of Amgen (AMGN) moved sharply higher today, but the exact reason for the move is unknown. The stock was up over 3% at the time this content was written. Recently, Amgen and AstraZeneca announced a breakthrough therapy designation for Tezepelumab, a treatment they jointly developed for patients with severe asthma. A buy signal was […]
Read Article
In today’s video, I discuss the early gap-up start to Monday’s trade and what could have caused it, as well as this week’s events. Thursday could be the day that the market moves a great deal, depending on the CPI report.
Read Article
Yesterday, September 6th, was the supposed deadline for China to come to the table for agreement on trade tariffs. They did not, but there was no implementation of any new tariffs – especially the $200 billion level that was warned. Today, Friday the 7th, could have been the day the tariffs were implemented but were […]
Read Article
We switch attention from Trump tweets to Elon Musk doobie hits. If you follow me on Twitter, you’ll occasionally see me rant about moral fiber. I’m not one to judge, but it completely throws me through a loop why Elon Musk thought his actions on Joe Rogan’s podcast were in good form. Especially now! Oh […]
Read Article
Zealand Pharma (ZEAL) was up sharply today on news of a deal with Royalty Pharma. Zeal reported it sold royalty streams and milestones to Royalty Pharma for $205M. This news caused ZEAL shares to rise over 15% on the news, but it is questionable if this will result in further upside. Here’s an overview of […]
Read Article
We saw some big moves in the biotech/healthcare space today. One of the biggest movers was Arrowhead Pharmaceuticals (ARWR). The stock moved up over 40% during the peak of the session, reaching a high of $22.39 before gradually pulling back to around $19 per share. The stock was up due to positive results on a […]
Read Article
It has been a rough few days for some of the beloved Nasdaq names. I break down three stocks with potential buy-side opportunities. See what I have to say about $NFLX, $AMZN and $WDAY for potential entry points and risk parameters.
Read Article
We choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.